Axogen Inc (AXGN)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

13631 PROGRESS BLVD. ALACHUA, FL 32615

Axogen is a regenerative medicine company with a portfolio of products and technologies for peripheral nerve reconstruction and regeneration. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body and their damage can result in the loss of function and feeling. Co.'s product portfolio includes: Avance Nerve Graft, an allograft nerve for bridging nerve discontinuities (a gap created when the nerve is severed); AxoGuard Nerve Connector, a coaptation aid allowing for close approximation of severed nerves; and AxoGuard Nerve Protector, a bioscaffold used to reinforce a coaptation site, wrap a partially severed nerve or isolate and protect nerve tissue.

Data based on most recent fiscal year report
Market Cap514.294 Million Shares Outstanding39.47 Million Avg Volume675.45 Thousand
1-Yr BETA vs S&P TR1.258 Current Ratio11.58 Quick Ratio10.66
View SEC Filings from AXGN instead.

View recent insider trading info

Funds Holding AXGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AXGN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

13 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RUDELIUS ROBERT JAMES

  • Director
45,592 2020-01-01 2

ZADEREJ KAREN L. CEO

  • Officer
  • Director
622,680 2020-01-01 5

FREITAG GREGORY GENE GENERAL COUNSEL

  • Officer
  • Director
101,543 2019-12-18 2

FRIEDMAN MARK LOUIS VP,REGULATORY & QUALITY

  • Officer
2,127 2019-12-18 3

DEVINNEY ERICK WAYNE VP, CLINICAL&TRANSLATIONAL SC

  • Officer
42,840 2019-12-18 2

DONOVAN MICHAEL PATRICK VP OPERATIONS

  • Officer
26,041 2019-12-18 4

MARIANI PETER J CHIEF FINANCIAL OFFICER

  • Officer
12,433 2019-12-18 2

GOLD MARK STEPHEN

  • Director
326,771 2019-12-03 4

BLACKFORD QUENTIN S. EVP CHIEF FINANCIAL OFFICER

  • Officer
69,754 2019-09-10 4

NEELS GUIDO J

  • Director
0 2019-09-03 1

WENDELL AMY MCBRIDE

  • Director
0 2019-09-03 2

LEVINE ALAN M

  • Director
0 2019-09-03 3

HANSEN DAVID K VP FINANCE & TREASURER

  • Officer
0 2019-08-21 3

GROOMS JAMIE MARK

  • Director
0 2019-08-14 1

MARTINEZ MARIA D. CHIEF HUMAN RESOURCES OFFICER

  • Officer
2,000 2019-08-14 1

BILLET ISABELLE CHIEF STRATEGY AND BD OFFICER

  • Officer
5,635 2019-08-13 1

COLLERAN LISA N

  • Director
18,674 2019-06-06 0

MANDATO JOSEPH M

  • Director
0 2019-05-16 0

GINGRICH JON S. CHIEF COMMERCIAL OFFICER

  • Officer
4,190 2019-02-15 2

SANDBERG ERIC CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-01-21 0

MCCARREY SHAWN F SVP SALES

  • Officer
0 2019-01-03 0

SCOPELIANOS ANGELO VP RESEARCH & DEVELOPMENT

  • Officer
0 2018-12-27 0

LEACH KEVIN VICE PRESIDENT

  • Officer
No longer subject to file 2018-08-17 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2018-07-23 0

ESSEX WOODLANDS FUND IX, L.P.

  • 10% Owner
3,711,111 2017-11-20 0

ENGELS JOHN P VP

  • Officer
No longer subject to file 2017-06-08 0

ESSEX WOODLANDS FUND IX, L.P.

ESSEX WOODLANDS FUND IX-GP, L.P.

ESSEX WOODLANDS IX, LLC

  • 10% Owner
4,861,111 2015-08-26 0

JOHNSTON LEE ROBERT JR CHIEF FINACIAL OFFICER

  • Officer
25,000 2015-06-02 0

SCHIAPARELLI JILL F CHIEF MARKETING OFFICER

  • Officer
0 2014-12-29 0

HARPER JOHN FREDERICK

  • Director
0 2014-01-02 0

HOPFENSPIRGER LARRY

  • Director
  • 10% Owner
0 2012-11-12 0

HEDGER BRADLEY JAY VICE PRESIDENT, SALES

  • Officer
0 2011-12-16 0

DE NOVO VENTURES II, L.P.

DE NOVO MANAGEMENT II, L.L.C.

  • 10% Owner
1,426,392 2011-09-30 0

SALOVICH ELMER

  • Director
100,000 2011-02-18 0

HELLERVIK LOWELL WALDO

  • Director
15,500 2011-01-26 0

BRINK SANFORD M

  • Director
345,280 2010-11-01 0

HEANEY TIMOTHY MICHAEL

  • Director
0 2010-11-01 0

WORMS-LYNCH KEVIN CHRISTOPHER

  • Director
0 2010-11-01 0

PERIAKARUPPAN RAMANATHAN

  • Director
219,363 2010-02-09 0

BERLIN JUDD A

  • Director
0 2008-09-26 0

SIGG DANIEL C

  • Director
0 2008-09-26 0

ROLLWAGEN C ANDREW

  • Director
0 2008-09-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RUDELIUS ROBERT JAMES - Director

2020-01-01 M 13,000 d 0 45,592.00 direct

ZADEREJ KAREN L. - Director - Officer CEO

2020-01-01 D 10,112 $17.34 d 622,680 622,680.00 direct

RUDELIUS ROBERT JAMES - Director

2020-01-01 F 1,999 $17.89 d 45,592 45,592.00 direct

ZADEREJ KAREN L. - Director - Officer CEO

2020-01-01 A 40,000 a 632,792 622,680.00 direct

RUDELIUS ROBERT JAMES - Director

2020-01-01 M 13,000 $2.75 a 47,591 45,592.00 direct

ZADEREJ KAREN L. - Director - Officer CEO

2019-12-18 A 6,250 a 599,530 599,530.00 direct

DEVINNEY ERICK WAYNE - Officer VP, CLINICAL&TRANSLATIONAL SC

2019-12-18 F 281 $16.73 d 42,840 42,840.00 direct

FRIEDMAN MARK LOUIS - Officer VP,REGULATORY & QUALITY

2019-12-18 A 750 a 2,310 2,127.00 direct

DONOVAN MICHAEL PATRICK - Officer VP OPERATIONS

2019-12-18 F 183 $16.73 d 26,041 26,041.00 direct

MARIANI PETER J - Officer CHIEF FINANCIAL OFFICER

2019-12-18 F 1,049 $16.73 d 12,433 12,433.00 direct

DEVINNEY ERICK WAYNE - Officer VP, CLINICAL&TRANSLATIONAL SC

2019-12-18 A 1,150 a 43,121 42,840.00 direct

FREITAG GREGORY GENE - Director - Officer GENERAL COUNSEL

2019-12-18 F 567 $16.73 d 101,543 101,543.00 direct

DONOVAN MICHAEL PATRICK - Officer VP OPERATIONS

2019-12-18 A 750 a 26,224 26,041.00 direct

MARIANI PETER J - Officer CHIEF FINANCIAL OFFICER

2019-12-18 A 3,800 a 13,482 12,433.00 direct

FRIEDMAN MARK LOUIS - Officer VP,REGULATORY & QUALITY

2019-12-18 F 183 $16.73 d 2,127 2,127.00 direct

FREITAG GREGORY GENE - Director - Officer GENERAL COUNSEL

2019-12-18 A 1,850 a 102,110 101,543.00 direct

GOLD MARK STEPHEN - Director by trust-see footnote

2019-12-03 G 7,000 d 326,771 326,771.00 indirect
Click here to report any possible errors with this stock listing.

Elevate your investments